Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Modern Rheumatology
Published in: Modern Rheumatology 3/2011

01-06-2011 | Case Report

Disseminated cutaneous and visceral Kaposi’s sarcoma in a patient with rheumatoid arthritis receiving corticosteroids and tacrolimus

Authors: Takashi Taniguchi, Yoshihide Asano, Makiko Kawaguchi, Asako Kogure, Hiroshi Mitsui, Makoto Sugaya, Shinichi Sato

Published in: Modern Rheumatology | Issue 3/2011

Login to get access

Abstract

Kaposi’s sarcoma (KS) is a vascular lesion of low-grade malignant potential caused by the complex interactions between geographic, genetic, environmental, and immunological factors. We recently experienced a rare case of KS associated with rheumatoid arthritis in a patient receiving corticosteroids and tacrolimus; the KS demonstrated unusually aggressive clinical behavior. We herein report the details of the clinical course and discuss the possible contribution of corticosteroids and tacrolimus to the development of aggressive KS in the present case.
Literature
1.
Martin RW 3rd, Hood AF, Farmer ER. Kaposi sarcoma. Medicine (Baltimore). 1993;72:245–61.
2.
Casoli P, Tumiati B. Rheumatoid arthritis, corticosteroid therapy and Kaposi’s sarcoma: a coincidence? A case and review of literature. Clin Rheumatol. 1992;11:432–5.PubMedCrossRef
3.
Cohen CD, Horster S, Sander CA, Bogner JR. Kaposi’s sarcoma associated with tumour necrosis factor alpha neutralising therapy. Ann Rheum Dis. 2003;62:684.PubMedCrossRef
4.
Larbre JP, Nicolas JF, Collet P, Larbre B, Llorca G. Kaposi’s sarcoma in a patient with rheumatoid arthritis possible responsibility of captopril in the development of lesions. J Rheumatol. 1991;18:476–7.PubMed
5.
Louthrenoo W, Kasitanon N, Mahanuphab P, Bhoopat L, Thongprasert S. Kaposi’s sarcoma in rheumatic diseases. Semin Arthritis Rheum. 2003;32:326–33.PubMed
6.
Vincent T, Moss K, Colaco B, Venables PJ. Kaposi’s sarcoma in two patients following low-dose corticosteroid treatment for rheumatological disease. Rheumatology (Oxford). 2000;39:1294–6.CrossRef
7.
Frances C. Kaposi’s sarcoma after renal transplantation. Nephrol Dial Transplant. 1998;13:2768–73.PubMedCrossRef
8.
Basu A, Contreras AG, Datta D, Flynn E, Zeng L, Cohen HT, et al. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res. 2008;68:5689–98.PubMedCrossRef
9.
Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med. 2005;352:1317–23.PubMedCrossRef
10.
Guo WX, Antakly T. AIDS-related Kaposi’s sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am J Pathol. 1995;146:727–34.PubMed
11.
Rady PL, Hodak E, Yen A, Memar O, Trattner A, Feinmesser M, et al. Detection of human herpesvirus-8 DNA in Kaposi’s sarcomas from iatrogenically immunosuppressed patients. J Am Acad Dermatol. 1998;38:429–37.PubMedCrossRef
Metadata
Title
Disseminated cutaneous and visceral Kaposi’s sarcoma in a patient with rheumatoid arthritis receiving corticosteroids and tacrolimus
Authors
Takashi Taniguchi
Yoshihide Asano
Makiko Kawaguchi
Asako Kogure
Hiroshi Mitsui
Makoto Sugaya
Shinichi Sato
Publication date
01-06-2011
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 3/2011
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-010-0389-0

Other articles of this Issue 3/2011

Modern Rheumatology 3/2011 Go to the issue

Letter

FDG-PET/CT of polymyalgia rheumatica

Original Article

Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up

Case Report

Polymyositis associated with autoimmune hepatitis, primary biliary cirrhosis, and autoimmune thrombocytopenic purpura

Review Article

The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants

Original Article

Therapeutic effect of D1-like dopamine receptor antagonist on collagen-induced arthritis of mice

Original Article

Two subtypes of Churg–Strauss syndrome with neuropathy: the roles of eosinophils and ANCA
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits